Company Description
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC.
It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index.
BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
| Country | United States |
| Founded | 2005 |
| Industry | Asset Management |
| Sector | Financials |
| CEO | Charles Choon Sik Park |
Contact Details
Address: 100 Bellevue Parkway Wilmington, Delaware 19809 United States | |
| Phone | (888) 825-2257 |
Stock Details
| Ticker Symbol | BME |
| Exchange | NYSE |
| Reporting Currency | USD |
| CIK Code | 0001314966 |
| CUSIP Number | 09250W107 |
| ISIN Number | US09250W1071 |
Key Executives
| Name | Position |
|---|---|
| Charles Choon Sik Park | Chief Compliance Officer and Anti-Money Laundering Officer |
| Thomas P. Callan C.F.A. | Portfolio Manager |
| Kyle G. McClements C.F.A. | Portfolio Manager |
| Dr. Erin Xie Ph.D. | Portfolio Manager |
| Christopher M. Accettella | Portfolio Manager |
| Jeffrey Gene Lee | Portfolio Manager |
| Dr. Xiang Liu Ph.D. | Portfolio Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 2, 2024 | SC TO-C | Filing |
| Jun 5, 2024 | DEF 14A | Other definitive proxy statements |
| May 28, 2024 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |
| Mar 14, 2024 | N-CEN | Filing |
| Mar 6, 2024 | N-CSR | Filing |
| Feb 26, 2024 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |
| Jan 26, 2024 | 40-17G | Filing |
| Nov 28, 2023 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |
| Sep 1, 2023 | N-CSRS | Filing |
| Aug 25, 2023 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) |